Clinical Trial Update: Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating intraperitoneal paclitaxel plus systemic therapy versus systemic therapy alone in gastric cancer with peritoneal metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Magnus Nilsson | Conditions: Gastric Cancer Peritoneal Metastases | Phase 3 | Status: RECRUITING